Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk

Despite numerous studies on major depressive disorder (MDD) susceptibility, the precise underlying molecular mechanism has not been elucidated which restricts the development of etiology-based disease-modifying drug. Major depressive disorder treatment is still symptomatic and is the leading cause o...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Ankit, Singh, Priyanka, Gupta, Hitesh, Kaur, Harpreet, Kanojia, Neha, Guin, Debleena, Sood, Mamta, Chadda, Rakesh Kumar, Yadav, Jyoti, Vohora, Divya, Saso, Luciano, Kukreti, Ritushree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514561/
https://www.ncbi.nlm.nih.gov/pubmed/31018568
http://dx.doi.org/10.3390/ijms20081993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514561/
https://www.ncbi.nlm.nih.gov/pubmed/31018568
http://dx.doi.org/10.3390/ijms20081993

Ejemplares similares